Oricell Announces FDA Clearance of IND Application for OriCAR-017
29 Jan 2024 //
PR NEWSWIRE
Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving Way for Global Impact
10 Aug 2023 //
PR NEWSWIRE
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
28 Feb 2023 //
PR NEWSWIRE
In push to expand its CAR-T therapies to US, Oricell raises additional $45M
28 Feb 2023 //
ENDPTS
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017
30 Jan 2023 //
PR NEWSWIRE
OriCell Therapeutics Raises Over $120M in Series B Financing
01 Aug 2022 //
PRNEWSWIRE